This inventor holds 1 USPTO granted patent. Top assignee: Lek, Tovarna Farmacevtskih in Kemicnik Izdelkov. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Sandi Borisek: Innovator in Pharmaceutical Chemistry
Introduction
Sandi Borisek is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of antibiotics. His work has led to advancements that are valuable in treating severe infections.
Latest Patents
Sandi Borisek holds a patent for a process titled "Process for the preparation of ceftriaxon disodium salt hemiheptahydrate." This innovative method describes a new and improved process for preparing ceftriaxon disodium salt hemiheptahydrate, which is a third-generation cephalosporin antibiotic. The process involves converting a specific disodium salt with a reactive derivative in a water solution, resulting in a highly pure compound with a high total yield.
Career Highlights
Sandi Borisek is associated with Lek, Tovarna Farmacevtskih in Kemicnik Izdelkov, a prominent pharmaceutical company in Slovenia. His work at Lek has allowed him to focus on the development of essential medications that address critical health issues. His expertise in pharmaceutical processes has been instrumental in advancing the company's research and development efforts.
Collaborations
Throughout his career, Sandi has collaborated with several professionals in the field, including Natasa H Milac and Igor Langof. These collaborations have fostered a productive environment for innovation and have contributed to the successful development of new pharmaceutical products.
Conclusion
Sandi Borisek's contributions to pharmaceutical chemistry, particularly through his patent on ceftriaxon disodium salt hemiheptahydrate, highlight his role as an innovator in the field. His work continues to impact the treatment of heavy infections, showcasing the importance of research and development in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile